Showing results (81-90 of 207) with videos related to
Sort By:
Pageof 21
Journal of Experimental Orthopaedics|September 22, 2020
Sagittal knee kinematics in relation with the posterior tibia slope during jump landing after an anterior cruciate ligament reconstructionMichèle N J Keizer, Juha M Hijmans, Alli Gokeler, et al.The Science of the Total Environment|December 12, 2019
Mid-term post-fire losses of nitrogen and phosphorus by overland flow in two contrasting eucalypt stands in north-central PortugalD Serpa, R V Ferreira, A I Machado, et al.Clinical Pharmacokinetics|July 9, 2010
Clinical pharmacokinetics of therapeutic monoclonal antibodiesRon J Keizer, Alwin D R Huitema, Jan H M Schellens, et al.Journal of Chromatography. B, Biomedical Sciences and Applications|March 7, 1997
Chromatographic analysis of the enantiomers of ifosfamide and some of its metabolites in plasma and urineG P Kaijser, J H Beijnen, A Bult, et al.Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA|June 23, 2022
Higher return to pre-injury type of sports after revision anterior ligament reconstruction with lateral extra-articular tenodesis compared to without lateral extra-articular tenodesisMichèle N J Keizer, Reinoud W Brouwer, Feike de Graaff, et al.Current Clinical Pharmacology|January 18, 2011
Pharmacodynamic biomarkers in model-based drug development in oncologyRon J Keizer, Jan H M Schellens, Jos H Beijnen, et al.Anti-Cancer Drugs|July 11, 1998
Use of granisetron in patients refractory to previous treatment with antiemeticsJ Carmichael, H J Keizer, D Cupissol, et al.Anticancer Research|September 1, 1996
Pharmacokinetics of ifosfamide, 2- and 3-dechloroethylifosfamide in plasma and urine of cancer patients treated with a 10-day continuous infusion of ifosfamideG P Kaijser, H J Keizer, J H Beijnen, et al.Scientific Reports|February 22, 2022
Prediction, validation, and uncertainties of a nation-wide post-fire soil erosion risk assessment in PortugalJ Parente, A Girona-García, A R Lopes, et al.Journal of Cancer Research and Clinical Oncology|January 1, 1995
Ifosfamide treatment as a 10-day continuous intravenous infusionH J Keizer, J Ouwerkerk, K Welvaart, et al.Pageof 21